Tier 3 drug shortages explained
Most drug shortages in Canada are handled quietly between manufacturers, wholesalers and pharmacies. A small number get a formal designation that changes how the whole system responds: Tier 3, Health Canada's category for shortages with the greatest potential impact on the health care system. rxstat maintains a live list of them here.
What earns the designation
Tier 3 is assigned by Health Canada, working with a multi-stakeholder committee of provinces, manufacturers and health system partners, when a shortage combines several bad properties: the drug treats a serious condition, few or no adequate alternatives exist, the shortage spans most or all suppliers, and the supply gap is expected to persist. It is a judgment about system impact, not just about how many boxes are missing.
What changes when it's Tier 3
A Tier 3 designation triggers coordinated national management: regular calls between Health Canada and the manufacturers, active searching for foreign supply that could be imported under an interim order or exceptional importation, conservation guidance to hospitals and pharmacies, and public communication. The children's analgesic and amoxicillin shortages of 2022 and several cancer-drug shortages ran through exactly this machinery.
What it means for you
If a drug you take is designated Tier 3, take the shortage seriously and early: alternatives are limited by definition, so the useful conversations (pharmacist first, prescriber if the whole molecule is affected) are worth having before your current supply runs low. Watch for official substitution guidance, which often accompanies Tier 3 shortages, and be wary of unusual online sellers, which multiply around exactly these drugs. Every Tier 3 drug page on rxstat shows the affected products, the manufacturers' estimates and the change history, and can email you when anything moves.
A note on reading the list
The Tier 3 list is short by design, usually a dozen or two drugs, not hundreds. A drug in widespread shortage without the designation is not necessarily fine; it may simply have adequate alternatives. The designation measures system risk, and the full shortage list measures availability. Read them together.
Written and maintained by rxstat. Sourced from Health Canada's mandatory shortage reporting; not medical advice. Disclaimer.